$9.37
N/A
At close: Aug 4, 5:00 PM EST
$8.85
-0.52-5.55%
Pre-Market: 4:09 AM EST
Ginkgo Bioworks Holdings Inc
DNANYSE
Ginkgo Bioworks Holdings Earnings & Forecasts
Ginkgo Bioworks Holdings (DNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ginkgo Bioworks Holdings Guidance
Ginkgo Bioworks Holdings (DNA) last issued guidance on November 6, 2025 for fiscal year 2025. The company guided revenue in the range of $167.00M - $187.00M for the period.
Compared to prior guidance, Ginkgo Bioworks Holdings maintained its revenue forecast from a prior range of $167.00M - $187.00M.
Ginkgo Bioworks Holdings has issued 14 guidance updates between August 15, 2022 and November 6, 2025. During this period, the company raised its outlook 3 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.70 | $-1.34 | $-1.39 | $-1.24 |
| Actual | $-0.92 | $-1.39 | $-1.41 | $-1.45 |
| Surprise | -31.4% | -3.73% | -1.44% | -16.9% |
| Revenue | ||||
| Estimate | $24.8M | $42.4M | $37.3M | $39.0M |
| Actual | $20.2M | $19.5M | $33.3M | $38.8M |
| Surprise | -18.6% | -54.0% | -10.8% | -0.33% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-1.26 |
| Revenue | |
| Consensus | $28.6M |
